Glutathione deficiency in type 2 diabetes impairs cytokine responses and control of intracellular bacteria
Open Access
- 1 June 2012
- journal article
- research article
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 122 (6), 2289-2300
- https://doi.org/10.1172/jci57817
Abstract
Individuals with type 2 diabetes are at increased risk of acquiring melioidosis, a disease caused by Burkholderia pseudomallei infection. Although up to half of melioidosis patients have underlying diabetes, the mechanisms involved in this increased susceptibility are unknown. We found that B. pseudomallei–infected PBMCs from diabetic patients were impaired in IL-12p70 production, which resulted in decreased IFN-γ induction and poor bacterial killing. The defect was specific to the IL-12–IFN-γ axis. Defective IL-12 production was also observed during Mycobacterium tuberculosis infection, in which diabetes is likewise known to be a strong risk factor. In contrast, IL-12 production in diabetic cells was not affected upon Salmonella enterica infection or in response to TLR2, -3, -4, and -5 ligands. Poor IL-12 production correlated with a deficiency in intracellular reduced glutathione (GSH) concentrations in diabetic patients. Addition of GSH or N-acetylcysteine to PBMCs selectively restored IL-12 and IFN-γ production and improved bacterial killing. Furthermore, the depletion of GSH in mice led to increased susceptibility to melioidosis, reduced production of IL-12p70, and poorer disease outcome. Our data thus establish a link between GSH deficiency in diabetes and increased susceptibility to melioidosis that may open up new therapeutic avenues to protect diabetic patients against some intracellular bacterial pathogens.This publication has 54 references indexed in Scilit:
- Glyburide Is Anti-inflammatory and Associated with Reduced Mortality in MelioidosisClinical Infectious Diseases, 2011
- Incidence, risk factors and clinical epidemiology of melioidosis: a complex socio-ecological emerging infectious disease in the Alor Setar region of Kedah, MalaysiaBMC Infectious Diseases, 2010
- Tuberculosis and diabetes mellitus: convergence of two epidemicsThe Lancet Infectious Diseases, 2009
- Phenotypic and Functional Characterization of Human Memory T Cell Responses to Burkholderia pseudomalleiPLoS Neglected Tropical Diseases, 2009
- Human Polymorphonuclear Neutrophil Responses to Burkholderia pseudomallei in Healthy and Diabetic SubjectsInfection and Immunity, 2009
- Glutathione dysregulation and the etiology and progression of human diseasesBiological Chemistry, 2008
- Role of Inducible Nitric Oxide Synthase and NADPH Oxidase in Early Control ofBurkholderia pseudomalleiInfection in MiceInfection and Immunity, 2006
- Melioidosis: Epidemiology, Pathophysiology, and ManagementClinical Microbiology Reviews, 2005
- Model of Differential Susceptibility to Mucosal Burkholderia pseudomallei InfectionInfection and Immunity, 2002
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001